newsfilter
← Latest News
Business Wire·

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

Updated statement includes Q1 2021 financial results Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company, o